Table 2.
Demographics of Participants of the Home Telemanagement for Patients with Ulcerative Colitis Trial
| Variable | Overall (n=47) | BAC (n=22) | UC HAT (n=25) | p value† |
|---|---|---|---|---|
| n (%) | n (%) | n (%) | ||
| Age (years+/− SD)* | 41.1+/−14.0 | 40.3+/−14.4 | 41.7+/−13.9 | 0.74 |
| Gender | ||||
| Male | 17 (36) | 7 (32) | 10 (40) | 0.56 |
| Female | 30 (64) | 15 (68) | 15 (60) | |
| Race | ||||
| White | 31 (66) | 15 (68) | 16 (64) | 0.76 |
| Other | 16 (34) | 7 (32) | 9 (36) | |
| Smoking Status | ||||
| Never | 31 (66) | 16 (73) | 15 (60 | |
| Former | 15 (32) | 5 (23) | 10 (40) | |
| Current | 1 (2) | 1 (4) | 0 (0) | 0.28 |
| Disease Extent | ||||
| Proctitis/Left | 22 (47) | 10 (45) | 12 (48) | |
| Sided Pancolitis | 25 (53) | 12 (55) | 13 (52) | |
| Steroid Use | ||||
| Yes | 5 (11) | 2 (9) | 3 (12) | 0.75 |
| No | 42 (89) | 20 (91) | 22 (88) | |
| Immune Suppressant Use | ||||
| Yes | 20 (43) | 6 (27) | 14 (56) | 0.05 |
| No | 27 (57) | 16 (73) | 11 (44) | |
| Infliximab Use | ||||
| Yes | 14 (30) | 7 (32) | 7 (28) | 0.78 |
| No | 33 (70) | 15 (68) | 18 (72) | |
| Disease Knowledge | ||||
| Limited | 7 (15) | 3 (14) | 4 (16) | |
| Good | 30 (64) | 15 (68) | 15 (60) | 0.83 |
| Excellent | 10 (21) | 4 (18) | 6 (24) | |
*
t-test comparing BAC to UC HAT group
†
χ2 test of association comparing BAC to UC HAT group